CK Life Sciences International Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
2,033
- Stock Symbol
-
00775
- Investments
-
18
- Share Price
-
$0.11
- (As of Friday Closing)
CK Life Sciences International General Information
Description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D. The company derives maximum revenue from the Nutraceutical segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.
Contact Information
Website
www.ck-lifesciences.comCorporate Office
- 2 Dai Fu Street
- Tai Po Industrial Estate
- Hong Kong
- Hong Kong
Corporate Office
- 2 Dai Fu Street
- Tai Po Industrial Estate
- Hong Kong
- Hong Kong
CK Life Sciences International Stock Performance
As of 16-May-2025, CK Life Sciences International’s stock price is $0.11. Its current market cap is $1.02B with 9.6B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.11 | $0.11 | $0.04 - $0.14 | $1.02B | 9.6B | 15.8M |
CK Life Sciences International Financials Summary
As of 31-Dec-2024, CK Life Sciences International has a trailing 12-month revenue of $708M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 1,197,038 | 1,197,038 | 1,455,726 | 1,650,657 |
| Revenue | 707,739 | 707,739 | 679,856 | 673,683 |
| EBITDA | 61,124 | 61,124 | 78,114 | 75,737 |
| Net Income | (16,218) | (16,218) | 2,203 | 16,851 |
| Total Assets | 1,389,653 | 1,389,653 | 1,439,337 | 1,441,961 |
| Total Debt | 785,685 | 785,685 | 759,007 | 761,012 |
CK Life Sciences International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CK Life Sciences International Investments & Acquisitions (18)
CK Life Sciences International’s most recent deal was a Early Stage VC with Pharus Diagnostics for . The deal was made on 25-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pharus Diagnostics | 25-Jul-2022 | Early Stage VC | Diagnostic Equipment | ||
| Nangiloc Colignan Farm (Farm Assets) | 01-Dec-2018 | Corporate Asset Purchase | Buildings and Property | ||
| Polynoma | 16-Nov-2017 | Merger/Acquisition | Biotechnology | ||
| Optigen Ingredients | 01-Jan-2014 | Merger/Acquisition | Specialty Chemicals | ||
| Cheetham Salt | 29-Nov-2012 | Merger/Acquisition | Food Products |
CK Life Sciences International ESG
Risk Overview
Risk Rating
Updated November, 30, 2024
31.12 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,631
Rank
Percentile
Pharmaceuticals
Industry
of 843
Rank
Percentile
Biotechnology
Subindustry
of 365
Rank
Percentile
CK Life Sciences International Exits (5)
CK Life Sciences International’s most recent exit was on 01-Jan-2014 from Optigen Ingredients. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Optigen Ingredients | 01-Jan-2014 | Completed |
|
||
| WEX Pharmaceuticals | 05-May-2011 | Completed |
|
||
| WEX Pharmaceuticals | 18-Oct-2009 | Completed |
|
||
| WEX Pharmaceuticals | 17-Oct-2007 | Completed |
|
||
| WEX Pharmaceuticals | PIPE | Completed |
CK Life Sciences International Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Polynoma | San Diego, CA | 2007 | |
| Lipa Pharmaceuticals | Minto, Australia | 1995 | |
| Cheetham Salt | Melbourne, Australia | 1888 |
CK Life Sciences International FAQs
-
When was CK Life Sciences International founded?
CK Life Sciences International was founded in 2000.
-
Where is CK Life Sciences International headquartered?
CK Life Sciences International is headquartered in Hong Kong, Hong Kong.
-
What is the size of CK Life Sciences International?
CK Life Sciences International has 2,033 total employees.
-
What industry is CK Life Sciences International in?
CK Life Sciences International’s primary industry is Biotechnology.
-
Is CK Life Sciences International a private or public company?
CK Life Sciences International is a Public company.
-
What is CK Life Sciences International’s stock symbol?
The ticker symbol for CK Life Sciences International is 00775.
-
What is the current stock price of CK Life Sciences International?
As of 16-May-2025 the stock price of CK Life Sciences International is $0.11.
-
What is the current market cap of CK Life Sciences International?
The current market capitalization of CK Life Sciences International is $1.02B.
-
What is CK Life Sciences International’s current revenue?
The trailing twelve month revenue for CK Life Sciences International is $708M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
